Lyle Camblos, Managing Partner & co-founder
Lyle Camblos is Managing Partner and co-founder of Atlantic Research Group, and serves as President of the Board of Directors of Pharmaceutical Service Network. In this role, Lyle manages finance and overall operations while mentoring team members on project management and clinical trial execution. He is the architect of ARG's corporate business framework, developing procedures and processes to manage explosive growth while providing a guiding hand to ensure the company retains the welcoming and supportive atmosphere of an agile small business. Prior to co-founding Atlantic Research Group, Lyle held positions in the clinical research industry, as varied as entry-level site management to clinical research associate and project manager: his career achievements include leadership roles in mid-sized and large multinational CROs. Lyle's clinical research expertise extends from
novel agents in orphan status phase I trials to post-marketing safety, surveillance, and oversight, including some of the largest and most successful supportive care and chemotherapeutic products on the market today. His knowledge beyond oncology includes plasma derivatives, endocrinology, immunology, and inflammatory disease indications. Lyle earned his Bachelor of Arts in Economics at the Virginia Military Institute.
When asked what makes Atlantic Research Group unique, Lyle answers, "ARG is at its core dedicated to unique, innovative, and responsive relationships with clients. Our people are builders: we use our experience, technology, and corporate system as tools to make successful clinical trials."